AI Article Synopsis

  • The study aimed to assess whether a structured outpatient parenteral antimicrobial therapy (OPAT) program, supervised by an infectious disease physician and managed by an OPAT nurse, reduced hospital readmission rates and complications.
  • A total of 428 patients requiring intravenous antibiotics after hospital discharge were analyzed, comparing outcomes before and after the implementation of this structured program.
  • Results showed a significant reduction in hospital readmissions related to OPAT (17.8% to 7%) and an increase in clinical cure rates (from 69.8% to 94.9%) following the program's implementation.

Article Abstract

Objective: To determine whether a structured OPAT program supervised by an infectious disease physician and led by an OPAT nurse decreased hospital readmission rates and OPAT-related complications and whether it affected clinical cure. We also evaluated predictors of readmission while receiving OPAT.

Patients: A convenience sample of 428 patients admitted to a tertiary-care hospital in Chicago, Illinois, with infections requiring intravenous antibiotic therapy after hospital discharge.

Methods: In this retrospective, quasi-experimental study, we compared patients discharged on intravenous antimicrobials from an OPAT program before and after implementation of a structured ID physician and nurse-led OPAT program. The preintervention group consisted of patients discharged on OPAT managed by individual physicians without central program oversight or nurse care coordination. All-cause and OPAT-related readmissions were compared using the χ test. Factors associated with readmission for OPAT-related problems at a significance level of < .10 in univariate analysis were eligible for testing in a forward, stepwise, multinomial, logistic regression to identify independent predictors of readmission.

Results: In total, 428 patients were included in the study. Unplanned OPAT-related hospital readmissions decreased significantly after implementation of the structured OPAT program (17.8% vs 7%; = .003). OPAT-related readmission reasons included infection recurrence or progression (53%), adverse drug reaction (26%), or line-associated issues (21%). Independent predictors of hospital readmission due to OPAT-related events included vancomycin administration and longer length of outpatient therapy. Clinical cure increased from 69.8% before the intervention to 94.9% after the intervention ( < .001).

Conclusion: A structured ID physician and nurse-led OPAT program was associated with a decrease in OPAT-related readmissions and improved clinical cure.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972539PMC
http://dx.doi.org/10.1017/ash.2022.330DOI Listing

Publication Analysis

Top Keywords

opat program
24
clinical cure
12
decreased hospital
8
hospital readmissions
8
opat
8
structured opat
8
hospital readmission
8
428 patients
8
patients discharged
8
implementation structured
8

Similar Publications

Background: Outpatient parenteral antibiotic therapy (OPAT) enhances patient safety, improves outcomes, and reduces healthcare costs by decreasing 30-day readmissions and adverse events. However, the optimal structure and follow-up protocols for OPAT programs remain undefined. Identifying high-risk patients for readmission and managing adverse drug events (ADEs) are critical components of OPAT care.

View Article and Find Full Text PDF

Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer.

Vaccine

December 2024

Monash University, Department of Oncology, School of Clinical Sciences, Melbourne, VIC, Australia; University of Bern, Department of Clinical Research (Medicine), Bern, Switzerland; University Cancer Centre, Bern, Switzerland.

Background: The COVID-19 pandemic has significantly impacted people with cancer. Initial vaccine studies excluded patients with malignancy. Immunocompromised individuals remain vulnerable to SARS-CoV-2, necessitating detailed understanding of vaccine response.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to assess improvements in health-related quality of life, as measured by the Short Form-36 (SF-36) scores, for patients in a Swiss Outpatient Parenteral Antimicrobial Therapy (OPAT) program from before discharge to 7-14 days after discharge.
  • - It involved a cohort of 33 patients from a public hospital in Switzerland, who completed a shortened version of the SF-36 questionnaire and additional questions on satisfaction at two different times.
  • - Results indicated significant improvements in three out of four domains (emotional role, social functioning, emotional well-being) and a high patient satisfaction rate, suggesting OPAT programs positively impact patients' health-related quality of life.
View Article and Find Full Text PDF

Antimicrobial stability is an important consideration for treatment planning and service delivery in outpatient parenteral antimicrobial therapy (OPAT) programmes. Regulation of stability assessment varies by region, and conflicting guidance and standards exist. This leads to disparity of equity in access and limits availability of certain antimicrobials for managing infections in the outpatient setting.

View Article and Find Full Text PDF

Outpatient parenteral antimicrobial therapy in pediatrics: the role of antimicrobial stewardship.

Antimicrob Steward Healthc Epidemiol

November 2024

Department of Pediatrics, Division of Pediatric Infectious Diseases, Stanford School of Medicine, Stanford, CA, USA.

This study characterized outpatient parenteral antimicrobial therapy (OPAT) orders and associated antimicrobial stewardship program (ASP) pharmacist recommendations made in a freestanding children's hospital. Recommendations occurred in over 50% of orders, indicating an opportunity for the review of OPAT by ASP pharmacists.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!